Tivorbex FDA Approval History
FDA Approved: Yes (First approved February 24, 2014)
Brand name: Tivorbex
Generic name: indomethacin
Dosage form: Capsules
Company: Iroko Pharmaceuticals, LLC
Treatment for: Pain
Tivorbex (indomethacin) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of mild to moderate acute pain.
Development timeline for Tivorbex
|Feb 25, 2014||Approval Iroko Pharmaceuticals Receives FDA Approval for Tivorbex|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.